These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. ESI-MSn and LC-ESI-MS studies to characterize forced degradation products of bosentan and a validated stability-indicating LC-UV method. Bansal G; Singh R; Saini B; Bansal Y J Pharm Biomed Anal; 2013 Jan; 72():186-97. PubMed ID: 22999302 [TBL] [Abstract][Full Text] [Related]
43. Development of a stability-indicating HPLC method of etifoxine with characterization of degradation products by LC-MS/TOF, 1H and 13C NMR. Djabrouhou N; Guermouche MH J Pharm Biomed Anal; 2014 Nov; 100():11-20. PubMed ID: 25117950 [TBL] [Abstract][Full Text] [Related]
44. Use of LC-MS/TOF, LC-MS(n), NMR and LC-NMR in characterization of stress degradation products: Application to cilazapril. Narayanam M; Sahu A; Singh S J Pharm Biomed Anal; 2015; 111():190-203. PubMed ID: 25890215 [TBL] [Abstract][Full Text] [Related]
45. LC determination of glimepiride and its related impurities. Khan MA; Sinha S; Vartak S; Bhartiya A; Kumar S J Pharm Biomed Anal; 2005 Oct; 39(5):928-43. PubMed ID: 16040224 [TBL] [Abstract][Full Text] [Related]
46. pH-Dependent stability of azithromycin in aqueous solution and structure identification of two new degradation products. Saita MG; Aleo D; Melilli B; Mangiafico S; Cro M; Sanfilippo C; Patti A J Pharm Biomed Anal; 2018 Sep; 158():47-53. PubMed ID: 29860178 [TBL] [Abstract][Full Text] [Related]
47. Isolation, identification and determination of the major degradation product in alprazolam tablets during their stability assay. Huidobro AL; Rupérez FJ; Barbas C J Pharm Biomed Anal; 2007 Jun; 44(2):404-13. PubMed ID: 17250986 [TBL] [Abstract][Full Text] [Related]
48. Cloud-point extraction is compatible with liquid chromatography coupled to electrospray ionization mass spectrometry for the determination of antazoline in human plasma. Giebułtowicz J; Kojro G; Piotrowski R; Kułakowski P; Wroczyński P J Pharm Biomed Anal; 2016 Sep; 128():294-301. PubMed ID: 27289300 [TBL] [Abstract][Full Text] [Related]
49. The stability of biapenem and structural identification of impurities in aqueous solution. Xia M; Hang TJ; Zhang F; Li XM; Xu XY J Pharm Biomed Anal; 2009 May; 49(4):937-44. PubMed ID: 19278804 [TBL] [Abstract][Full Text] [Related]
50. Validated stability indicating assay method of olaparib: LC-ESI-Q-TOF-MS/MS and NMR studies for characterization of its new hydrolytic and oxidative forced degradation products. Thummar M; Kuswah BS; Samanthula G; Bulbake U; Gour J; Khan W J Pharm Biomed Anal; 2018 Oct; 160():89-98. PubMed ID: 30075398 [TBL] [Abstract][Full Text] [Related]
51. Application of high-performance liquid chromatography hyphenated techniques for identification of degradation products of cefpodoxime proxetil. Fukutsu N; Kawasaki T; Saito K; Nakazawa H J Chromatogr A; 2006 Oct; 1129(2):153-9. PubMed ID: 16846608 [TBL] [Abstract][Full Text] [Related]
52. Determination of antazoline hydrochloride in Beagle dog plasma by HPLC-UV and its application to pharmacokinetics. Li X; Chu Y; Ke Y; Wang L; Yu T; Hao L J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Jun; 929():97-101. PubMed ID: 23669609 [TBL] [Abstract][Full Text] [Related]
53. Stability-Indicating Related Substances HPLC Method for Droxidopa and Characterization of Related Substances Using LC-MS and NMR. Kumar T; Ramya M; Arockiasamy Xavier SJ J Chromatogr Sci; 2016 Nov; 54(10):1761-1770. PubMed ID: 27601041 [TBL] [Abstract][Full Text] [Related]
54. A multidisciplinary approach to identify a degradation product in a pharmaceutical dosage form. Pan C; Guan J; Lin M J Pharm Biomed Anal; 2011 Mar; 54(4):855-9. PubMed ID: 21129882 [TBL] [Abstract][Full Text] [Related]
55. Identification, isolation and characterization of a new degradation product in sultamicillin drug substance. Kumar VJ; Gupta PB; Kumar KS; Ray UK; Sreenivasulu B; Kumar GS; Rao KR; Sharma HK; Mukkanti K J Pharm Biomed Anal; 2011 Feb; 54(3):582-7. PubMed ID: 20934824 [TBL] [Abstract][Full Text] [Related]
56. A novel process related impurity and forced degradation study of synthetic wogonin: development of a liquid chromatographic method for purity control. Xia Y; Wu C; Liu W; Feng F; Li Z J Pharm Biomed Anal; 2012 Dec; 71():168-72. PubMed ID: 22906689 [TBL] [Abstract][Full Text] [Related]
57. Conjunctival temperature: a measure of ocular decongestant and anti-inflammatory activity. Salem H; Dunn BJ; Loux JJ Ann Ophthalmol; 1975 Jun; 7(6):819-24. PubMed ID: 1147509 [TBL] [Abstract][Full Text] [Related]
58. A novel green spectrofluorimetric method for simultaneous determination of antazoline and tetryzoline in their ophthalmic formulation. Hussein OG; Ahmed DA; Abdelkawy M; Rezk MR; Rostom Y Luminescence; 2024 Mar; 39(3):e4728. PubMed ID: 38516711 [TBL] [Abstract][Full Text] [Related]
59. Stability-indicating reversed-phase HPLC method development and characterization of impurities in vortioxetine utilizing LC-MS, IR and NMR. Liu L; Cao N; Ma X; Xiong K; Sun L; Zou Q; Yao L J Pharm Biomed Anal; 2016 Jan; 117():325-32. PubMed ID: 26412721 [TBL] [Abstract][Full Text] [Related]
60. A novel automated hydrophilic interaction liquid chromatography method using diode-array detector/electrospray ionization tandem mass spectrometry for analysis of sodium risedronate and related degradation products in pharmaceuticals. Bertolini T; Vicentini L; Boschetti S; Andreatta P; Gatti R J Chromatogr A; 2014 Oct; 1365():131-9. PubMed ID: 25242223 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]